These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Who Would Be Branded With Failure? Stevenson LW Circulation; 2017 Oct; 136(15):1359-1361. PubMed ID: 28993370 [No Abstract] [Full Text] [Related]
3. Low systolic blood pressure for predicting all-cause mortality in patients hospitalised with heart failure: a systematic review and meta-analysis. Zhang Y; Wang C; Zhang J; Zhang H; Yin Z; Chen Y; Xie Q Eur J Prev Cardiol; 2019 Mar; 26(4):439-443. PubMed ID: 29939079 [No Abstract] [Full Text] [Related]
4. Establishing prognosis in heart failure: a multimarker approach. Ketchum ES; Levy WC Prog Cardiovasc Dis; 2011; 54(2):86-96. PubMed ID: 21875508 [TBL] [Abstract][Full Text] [Related]
5. Generalizability and Implications of the H Segar MW; Patel KV; Berry JD; Grodin JL; Pandey A Circulation; 2019 Apr; 139(15):1851-1853. PubMed ID: 30958721 [No Abstract] [Full Text] [Related]
6. Prevention of "Failure": Is It a Failure of Prevention? Nambi V; Deswal A; Ballantyne CM Circulation; 2018 Jan; 137(2):106-108. PubMed ID: 29311345 [No Abstract] [Full Text] [Related]
7. Prognostic value of six-minute walk distance in patients with heart failure: A meta-analysis. Fan Y; Gu X; Zhang H Eur J Prev Cardiol; 2019 Apr; 26(6):664-667. PubMed ID: 30160522 [No Abstract] [Full Text] [Related]
8. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Olivotto I; Cecchi F; Poggesi C; Yacoub MH Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549 [No Abstract] [Full Text] [Related]
9. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. Kelly JP; Cooper LB; Gallup D; Anstrom KJ; Chen HH; Redfield MM; O'Connor CM; Mentz RJ; Hernanadez AF; Felker GM Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514750 [TBL] [Abstract][Full Text] [Related]
10. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation. Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751 [TBL] [Abstract][Full Text] [Related]
11. Advanced heart failure: a call to action. Russell SD; Miller LW; Pagani FD Congest Heart Fail; 2008; 14(6):316-21. PubMed ID: 19076855 [TBL] [Abstract][Full Text] [Related]
12. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792 [TBL] [Abstract][Full Text] [Related]
13. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial. Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M; Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000 [TBL] [Abstract][Full Text] [Related]
14. Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward. Eapen ZJ; Tang WH; Felker GM; Hernandez AF; Mahaffey KW; Lincoff AM; Roe MT Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):594-600. PubMed ID: 22811505 [No Abstract] [Full Text] [Related]
15. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Gorodeski EZ; Chu EC; Chow CH; Levy WC; Hsich E; Starling RC Circ Heart Fail; 2010 Nov; 3(6):706-14. PubMed ID: 20798278 [TBL] [Abstract][Full Text] [Related]
16. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction. Pavlović A; Polovina M; Ristić A; Seferović JP; Veljić I; Simeunović D; Milinković I; Krljanac G; Ašanin M; Oštrić-Pavlović I; Seferović PM Eur J Prev Cardiol; 2019 Jan; 26(1):72-82. PubMed ID: 30335505 [TBL] [Abstract][Full Text] [Related]
17. Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials. Ibrahim NE; Gaggin HK; Konstam MA; Januzzi JL Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27582282 [TBL] [Abstract][Full Text] [Related]
18. Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients. Denardo SJ; Vock DM; Schmalfuss CM; Young GD; Tcheng JE; O'Connor CM Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27382090 [TBL] [Abstract][Full Text] [Related]
20. New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure. de Groote P; Cohen A; Juillière Y; Damy T Arch Cardiovasc Dis; 2017 Jan; 110(1):1-6. PubMed ID: 28082242 [No Abstract] [Full Text] [Related] [Next] [New Search]